Genisphere Licenses RNA Amplification, microRNA Labeling Technologies to Affymetrix | GenomeWeb

Genisphere said this week that it has signed deals licensing its RNA target amplification and FlashTag Biotin microRNA labeling technologies to Affymetrix.

Genisphere said Affymetrix will use the technologies within its RNA microarray expression products, particularly for preclinical applications using formalin-fixed paraffin-embedded samples.

Financial terms of the arrangement were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.